0.000435452535673596 -0.000200978093387828 0.00542640852147117 0.00901051785355395 0.00475648154351181 0.00664902525624711 0.0102163864138809 0.00251222616734776
Sign Up Today X
Thanks for submitting the form.
Stockreport

Liom achieves Breakthrough in Miniaturization of its Non-invasive Biomarker Monitoring Tech Platform and extends Series A Funding to CHF 38 Million [Yahoo! Finance]

General Electric Company (GE)  More Company Research Source: Yahoo! Finance
Last general electric company earnings: 4/30 04:02 pm Check Earnings Report
US:NYSE Investor Relations: ge.com/investor-relations/overview
biomarker monitoring and the developer of the world's first non-invasive glucose-monitoring wearable, today announced a CHF 13 million extension of its Series A financing round. This brings its total Series A to CHF 38 million and its total funding to date to CHF 63 million. The round was led by previous lead investors, with new participation from Red Bull Ventures, Marc Maurer (former co-CEO of On Running), Melih Odemis (former co-founder and CTO of Yemeksepeti), Alejo Costa Ribalta, partner of venture capital firm CRB Health Tech and former senior executive of Philips and GE Healthcare, and others. The new capital follows Liom's recent breakthrough in miniaturizing its proprietary Raman spectroscopy platform, having proven its ability to measure glucose non-invasively and as the world's only company calibration-free, i.e. requiring no needles to calibrate whatsoever, on over 130 subjects in the course of the past years. "Now, we can also be sure that we've not only proven the meth [Read more]
IMPACT SNAPSHOT EVENT TIME: GE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GE alerts
from News Quantified
GE
NEWS
GE
Earnings
GE
Analyst Actions
GE
SEC Filings
Stockreport

Liom achieves Breakthrough in Miniaturization of its Non-invasive Biomarker Monitoring Tech Platform and extends Series A Funding to CHF 38 Million [Yahoo! Finance]

General Electric Company  (GE) 
More Company Research Source: Yahoo! Finance
Last general electric company earnings: 4/30 04:02 pm Check Earnings Report
US:NYSE Investor Relations: ge.com/investor-relations/overview
biomarker monitoring and the developer of the world's first non-invasive glucose-monitoring wearable, today announced a CHF 13 million extension of its Series A financing round. This brings its total Series A to CHF 38 million and its total funding to date to CHF 63 million. The round was led by previous lead investors, with new participation from Red Bull Ventures, Marc Maurer (former co-CEO of On Running), Melih Odemis (former co-founder and CTO of Yemeksepeti), Alejo Costa Ribalta, partner of venture capital firm CRB Health Tech and former senior executive of Philips and GE Healthcare, and others. The new capital follows Liom's recent breakthrough in miniaturizing its proprietary Raman spectroscopy platform, having proven its ability to measure glucose non-invasively and as the world's only company calibration-free, i.e. requiring no needles to calibrate whatsoever, on over 130 subjects in the course of the past years. "Now, we can also be sure that we've not only proven the meth [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS